Skip to main content

GOLDMAN SACHS GROUP INC

Position in ANIK — Anika Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in ANIK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,159,230
+$1,574,292 QoQ
Shares Held
217,878
+32.1% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. ANIK ranks #39 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,159,230 217,878
2025-12-31 $1,584,938 164,926
2025-09-30 $610,764 64,975
2025-06-30 $274,497 25,945
2025-03-31 $781,318 51,984
2024-12-31 $1,130,555 68,685
2024-09-30 $2,191,556 88,727
2024-06-30 $1,896,127 74,857
2024-03-31 $1,954,021 76,930
2023-12-31 $1,829,613 80,742
2023-09-30 $1,537,048 82,504
2023-06-30 $1,566,359 60,291
2023-03-31 $1,439,043 50,106
2022-12-31 $1,373,291 46,395
2022-09-30 $1,619,065 68,028
2022-06-30 $3,296,596 147,697
2022-03-31 $2,534,025 100,917
2021-12-31 $390,117 10,888
2021-09-30 $1,285,864 30,213
2021-06-30 $2,068,828 47,790
2021-03-31 $1,846,440 45,267
2020-12-31 $3,077,091 67,987
2020-09-30 $3,561,295 100,630
2020-06-30 $4,688,216 124,257
2020-03-31 $6,463,523 223,574